MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2
Authors:
- Alexia Martínez de PazAPAlexia Martínez de Paz
- Leila KhajaviLKLeila Khajavi
- Hélène MartinHMHélène Martin
- Rafael Claveria-GimenoRCRafael Claveria-Gimeno
- Susanne Tom DieckSDSusanne Tom Dieck
- Manjinder Singh CheemaMCManjinder Singh Cheema
- Jose Vicente Sanchez-MutJSJose Vicente Sanchez-Mut
- Malgorzata M. MoksaMMMalgorzata M. Moksa
- Nick I. BrodieNBNick I. Brodie
- Taimoor I. SheikhTSTaimoor I. Sheikh
- Melissa E. FreemanMFMelissa E. Freeman
Preprint
Abstract
MeCP2 – a chromatin-binding protein associated with Rett syndrome – has two main isoforms, MeCP2-E1 and MeCP2-E2, with 96% amino acid identity differing in a few N-terminal amino acid residues. Previous studies have shown brain region-specific expression of these isoforms which, in addition to their different cellular localization and differential expression during brain development, suggest they may also have non-overlapping molecular mechanisms. However, differential functions of MeCP2-E1 and E2 remain largely unexplored. Here, we show that the N-terminal domains (NTD) of MeCP2-E1 and E2 modulate the ability of the methyl binding domain (MBD) to interact with DNA as well as influencing the turnover rates, binding dynamics, response to nuclear depolarization, and circadian oscillations of the two isoforms. Our proteomics data indicate that both isoforms exhibit unique interacting protein partners. Moreover, genome-wide analysis using ChIP-seq provide evidence for a shared as well as a specific regulation of different sets of genes. Our findings provide insight into the functional complexity of MeCP2 by dissecting differential aspects of its two isoforms. Significance: Whether the two E1 and E2 isoforms of MeCP2 have different structural and/or functional implications has been highly controversial and is not well known. Here we show that the relatively short N-terminal sequence variation between the two isoforms impinges them with an important DNA binding difference. Moreover, MeCP2-E1 and E2 exhibit a different cellular dynamic behavior and have some distinctive interacting partners. In addition, while sharing genome occupancy they specifically bind to several distinctive genes.Keywords
All Related Versions
- Published version: Epigenetics & Chromatin, 12 (1), 1.
This publication has 76 references indexed in Scilit:
- Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognitionCell Research, 2013
- TLS/FUS (translocated in liposarcoma/fused in sarcoma) regulates target gene transcription via single-stranded DNA response elementsProceedings of the National Academy of Sciences, 2012
- Neuronal activity modifies the DNA methylation landscape in the adult brainNature Neuroscience, 2011
- Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenesEuropean Journal of Human Genetics, 2011
- MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturationNeurobiology of Disease, 2011
- Context‐dependent resistance to proteolysis of intrinsically disordered proteinsProtein Science, 2011
- Integrative genomics viewerNature Biotechnology, 2011
- Unique Physical Properties and Interactions of the Domains of Methylated DNA Binding Protein 2Biochemistry, 2010
- Epigenetic regulation of TTF‐I‐mediated promoter–terminator interactions of rRNA genesThe EMBO Journal, 2008
- Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNACell, 1992